로수바스타틴 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "로수바스타틴" in Korean language version.

refsWebsite

Global rank Korean rank

16nih.gov

4^th place

11doi.org

2^nd place

3^rd place

8fda.gov

447^th place

433^rd place

7web.archive.org

1^st place

5semanticscholar.org

11^th place

310^th place

3drugs.com

399^th place

141^st place

2clincalc.com

3,912^th place

2,490^th place

2worldcat.org

5^th place

11^th place

2prnewswire.com

406^th place

621^st place

1books.google.com

3^rd place

9^th place

1latimes.com

22^nd place

169^th place

1lww.com

2,769^th place

1,748^th place

1webmd.com

1,169^th place

735^th place

1ama-assn.org

3,257^th place

2,201^st place

1clinicaltherapeutics.com

low place

1who.int

195^th place

98^th place

1cigna.com

low place

1aafp.org

1,916^th place

987^th place

1crestor.info

low place

1delawareonline.com

4,565^th place

low place

1reuters.com

49^th place

110^th place

1archive.today

14^th place

15^th place

1pqarchiver.com

490^th place

1,676^th place

1gmmmg.nhs.uk

low place

aafp.org (Global: 1,916^th place; Korean: 987^th place)

“Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Recommendation Statement”. 《American Family Physician》 95 (2). 2017년 1월 15일. 2020년 3월 31일에 확인함.

ama-assn.org (Global: 3,257^th place; Korean: 2,201^st place)

jama.ama-assn.org

Nissen SE, Nicholls SJ, Sipahi I 외 (2006). “Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial” (PDF). 《JAMA》 295 (13): 1556–65. doi:10.1001/jama.295.13.jpc60002. PMID 16533939. 2007년 9월 29일에 원본 문서 (PDF)에서 보존된 문서.

archive.today (Global: 14^th place; Korean: 15^th place)

Starkey, Jonathan (2010년 7월 1일). “AstraZeneca patent upheld”. 《The News Journal》 (Wilmington, Delaware). 2013년 1월 31일에 원본 문서에서 보존된 문서. 2012년 4월 25일에 확인함. (구독 필요)

books.google.com (Global: 3^rd place; Korean: 9^th place)

Fischer, Janos; Ganellin, C. Robin (2006). 《Analogue-based Drug Discovery》. John Wiley & Sons. 473쪽. ISBN 9783527607495.

cigna.com (Global: low place; Korean: low place)

“PPACA no cost-share preventive medications” (PDF). Cigna. 2020년 3월 30일에 확인함.

clincalc.com (Global: 3,912^th place; Korean: 2,490^th place)

“The Top 300 of 2021”. 《ClinCalc》. 2021년 2월 18일에 확인함.
“Rosuvastatin - Drug Usage Statistics”. 《ClinCalc》. 2021년 2월 18일에 확인함.

clinicaltherapeutics.com (Global: low place; Korean: low place)

Li, Yunxia; Jiang, Xuehua; Lan, Ke; Zhang, Ruoqi; Li, Xue; Jiang, Qian (2007년 10월 1일). “Pharmacokinetic Properties of Rosuvastatin After Single-Dose, Oral Administration in Chinese Volunteers: A Randomized, Open-Label, Three-Way Crossover Study”. 《Clinical Therapeutics》 29 (10): 2194–2203. doi:10.1016/j.clinthera.2007.10.005. ISSN 0149-2918. PMID 18042475.

crestor.info (Global: low place; Korean: low place)

“Core Data Sheet, Crestor Tablets” (PDF). AstraZeneca. June 17, 2003. May 8, 2005에 원본 문서 (PDF)에서 보존된 문서. March 20, 2005에 확인함. - NOTE: this is provider-oriented information and should not be used without the supervision of a physician.

delawareonline.com (Global: 4,565^th place; Korean: low place)

“AstraZeneca's Crestor patent upheld;No generic competition until 2016”. ^{[깨진 링크]}

doi.org (Global: 2^nd place; Korean: 3^rd place)

dx.doi.org

Aggarwal, RK; Showkathali, R (June 2013). “Rosuvastatin calcium in acute coronary syndromes”. 《Expert Opinion on Pharmacotherapy》 14 (9): 1215–1227. doi:10.1517/14656566.2013.789860. PMID 23574635. S2CID 20221457.
Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto JW (2003). “Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)”. 《Am J Cardiol》 92 (2): 152–60. doi:10.1016/S0002-9149(03)00530-7. PMID 12860216.
McTaggart F (Aug 2008). “Effects of statins on high-density lipoproteins: a potential contribution to cardiovascular benefit.”. 《Cardiovasc Drugs Ther》 22 (4): 321–38. doi:10.1007/s10557-008-6113-z. PMC 2493531. PMID 18553127.
Adams, S. P.; Sekhon, S. S.; Wright, J. M. (Nov 2014). “Lipid-lowering efficacy of rosuvastatin.”. 《Cochrane Database Syst Rev》 11 (11): CD010254. doi:10.1002/14651858.CD010254.pub2. PMC 6463960. PMID 25415541.
Wu HF, Hristeva N, Chang J, Liang X, Li R, Frassetto L, Benet LZ (September 2017). “Rosuvastatin Pharmacokinetics in Asian and White Subjects Wild Type for Both OATP1B1 and BCRP Under Control and Inhibited Conditions”. 《J Pharm Sci》 106 (9): 2751–2757. doi:10.1016/j.xphs.2017.03.027. PMC 5675025. PMID 28385543.
Sattar, N; Preiss, D; Murray, HM; Welsh, P; Buckley, BM; de Craen, AJ; Seshasai, SR; McMurray, JJ; Freeman, DJ; Jukema, JW; Macfarlane, PW; Packard, CJ; Stott, DJ; Westendorp, RG; Shepherd, J; Davis, BR; Pressel, SL; Marchioli, R; Marfisi, RM; Maggioni, AP; Tavazzi, L; Tognoni, G; Kjekshus, J; Pedersen, TR; Cook, TJ; Gotto, AM; Clearfield, MB; Downs, JR; Nakamura, H; Ohashi, Y; Mizuno, K; Ray, KK; Ford, I (2010년 2월 27일). “Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.”. 《Lancet》 375 (9716): 735–42. doi:10.1016/S0140-6736(09)61965-6. PMID 20167359. S2CID 11544414.
Nissen SE, Nicholls SJ, Sipahi I 외 (2006). “Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial” (PDF). 《JAMA》 295 (13): 1556–65. doi:10.1001/jama.295.13.jpc60002. PMID 16533939. 2007년 9월 29일에 원본 문서 (PDF)에서 보존된 문서.
Ashton E, Windebank E, Skiba M 외 (January 2010). “Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study”. 《Int J Cardiol》 146 (3): 404–7. doi:10.1016/j.ijcard.2009.12.028. PMID 20085851.
Adams, Stephen P.; Sekhon, Sarpreet S.; Wright, James M. (2014년 11월 21일). “Rosuvastatin for lowering lipids. Cochrane Database of Systematic Reviews”. 《The Cochrane Database of Systematic Reviews》 (John Wiley & Sons, Ltd) (11): CD010254. doi:10.1002/14651858.cd010254.pub2. PMC 6463960. PMID 25415541.
Li, Yunxia; Jiang, Xuehua; Lan, Ke; Zhang, Ruoqi; Li, Xue; Jiang, Qian (2007년 10월 1일). “Pharmacokinetic Properties of Rosuvastatin After Single-Dose, Oral Administration in Chinese Volunteers: A Randomized, Open-Label, Three-Way Crossover Study”. 《Clinical Therapeutics》 29 (10): 2194–2203. doi:10.1016/j.clinthera.2007.10.005. ISSN 0149-2918. PMID 18042475.
Bergman, Ebba; Lundahl, Anna; Fridblom, Patrik; Hedeland, Mikael; Bondesson, Ulf; Knutson, Lars; Lennernäs, Hans (2009년 12월 1일). “Enterohepatic Disposition of Rosuvastatin in Pigs and the Impact of Concomitant Dosing with Cyclosporine and Gemfibrozil”. 《Drug Metabolism and Disposition》 37 (12): 2349–2358. doi:10.1124/dmd.109.029363. ISSN 1521-009X. PMID 19773540. S2CID 24783238.

drugs.com (Global: 399^th place; Korean: 141^st place)

“Rosuvastatin Calcium Monograph for Professionals”. 《Drugs.com》. American Society of Health-System Pharmacists (AHFS). 2018년 12월 24일에 확인함.
“Rosuvastatin Use During Pregnancy”. 《Drugs.com》. 2019년 9월 27일. 2020년 3월 14일에 확인함.
“Top 100 Drugs for Q2 2013 by Sales”. 2013년 8월 24일에 확인함.

fda.gov (Global: 447^th place; Korean: 433^rd place)

fda.gov

“FDA Alert (03/2005) - Rosuvastatin Calcium (marketed as Crestor) Information”. U.S. Food and Drug Administration (FDA). 2005년 3월 14일. 2005년 3월 5일에 원본 문서에서 보존된 문서. 2005년 3월 20일에 확인함. - This page is subject to change; the date reflects the last revision date.
“Rosuvastatin Calcium (marketed as Crestor) Information”. 《U.S. Food and Drug Administration (FDA)》. 2015년 7월 10일. 2020년 3월 14일에 확인함.
“FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs”. U.S. Food and Drug Administration (FDA). 2019년 2월 9일.
“FDA Approves New Drug for Lowering Cholesterol”. Food and Drug Administration. 2003년 8월 12일. 2005년 2월 7일에 원본 문서에서 보존된 문서. 2005년 3월 20일에 확인함.
“FDA approves first generic Crestor”. Food and Drug Administration. 2016년 4월 29일. 2016년 5월 3일에 확인함.

accessdata.fda.gov

“Page 45 of FDA Drug Approval Package, Clinical Pharmacology Biopharmaceutics Review(s) (PDF)”. U.S. Food and Drug Administration (FDA). 2004년 1월 29일. 2016년 6월 22일에 확인함.
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021366s016ltr.pdf
“Drug Approval Package: Crestor (Rosuvastatin Calcium) NDA #021366”. 《accessdata.fda.gov》. 2004년 1월 29일. 2020년 3월 15일에 확인함.

gmmmg.nhs.uk (Global: low place; Korean: low place)

“COST COMPARISON CHARTS” (PDF). REGIONAL DRUG AND THERAPEUTICS CENTRE (NEWCASTLE). August 2018. 2018년 10월 20일에 원본 문서 (PDF)에서 보존된 문서. 2021년 5월 16일에 확인함.

latimes.com (Global: 22^nd place; Korean: 169^th place)

Alonso-Zaldivar, Ricardo (2005년 3월 3일). “FDA Advisory Targets Asian Patients”. 《Los Angeles Times》.

lww.com (Global: 2,769^th place; Korean: 1,748^th place)

journals.lww.com

Lee VW, Chau TS, Leung VP, Lee KK, Tomlinson B (December 2009). “Clinical efficacy of rosuvastatin in lipid management in Chinese patients in Hong Kong”. 《Chin. Med. J.》 122 (23): 2814–9. PMID 20092783.

nih.gov (Global: 4^th place; Korean: 4^th place)

ncbi.nlm.nih.gov

Aggarwal, RK; Showkathali, R (June 2013). “Rosuvastatin calcium in acute coronary syndromes”. 《Expert Opinion on Pharmacotherapy》 14 (9): 1215–1227. doi:10.1517/14656566.2013.789860. PMID 23574635. S2CID 20221457.
Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto JW (2003). “Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)”. 《Am J Cardiol》 92 (2): 152–60. doi:10.1016/S0002-9149(03)00530-7. PMID 12860216.
McTaggart F (Aug 2008). “Effects of statins on high-density lipoproteins: a potential contribution to cardiovascular benefit.”. 《Cardiovasc Drugs Ther》 22 (4): 321–38. doi:10.1007/s10557-008-6113-z. PMC 2493531. PMID 18553127.
Adams, S. P.; Sekhon, S. S.; Wright, J. M. (Nov 2014). “Lipid-lowering efficacy of rosuvastatin.”. 《Cochrane Database Syst Rev》 11 (11): CD010254. doi:10.1002/14651858.CD010254.pub2. PMC 6463960. PMID 25415541.
Wu HF, Hristeva N, Chang J, Liang X, Li R, Frassetto L, Benet LZ (September 2017). “Rosuvastatin Pharmacokinetics in Asian and White Subjects Wild Type for Both OATP1B1 and BCRP Under Control and Inhibited Conditions”. 《J Pharm Sci》 106 (9): 2751–2757. doi:10.1016/j.xphs.2017.03.027. PMC 5675025. PMID 28385543.
Lee VW, Chau TS, Leung VP, Lee KK, Tomlinson B (December 2009). “Clinical efficacy of rosuvastatin in lipid management in Chinese patients in Hong Kong”. 《Chin. Med. J.》 122 (23): 2814–9. PMID 20092783.
Sattar, N; Preiss, D; Murray, HM; Welsh, P; Buckley, BM; de Craen, AJ; Seshasai, SR; McMurray, JJ; Freeman, DJ; Jukema, JW; Macfarlane, PW; Packard, CJ; Stott, DJ; Westendorp, RG; Shepherd, J; Davis, BR; Pressel, SL; Marchioli, R; Marfisi, RM; Maggioni, AP; Tavazzi, L; Tognoni, G; Kjekshus, J; Pedersen, TR; Cook, TJ; Gotto, AM; Clearfield, MB; Downs, JR; Nakamura, H; Ohashi, Y; Mizuno, K; Ray, KK; Ford, I (2010년 2월 27일). “Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.”. 《Lancet》 375 (9716): 735–42. doi:10.1016/S0140-6736(09)61965-6. PMID 20167359. S2CID 11544414.
Nissen SE, Nicholls SJ, Sipahi I 외 (2006). “Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial” (PDF). 《JAMA》 295 (13): 1556–65. doi:10.1001/jama.295.13.jpc60002. PMID 16533939. 2007년 9월 29일에 원본 문서 (PDF)에서 보존된 문서.
Ashton E, Windebank E, Skiba M 외 (January 2010). “Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study”. 《Int J Cardiol》 146 (3): 404–7. doi:10.1016/j.ijcard.2009.12.028. PMID 20085851.
Adams, Stephen P.; Sekhon, Sarpreet S.; Wright, James M. (2014년 11월 21일). “Rosuvastatin for lowering lipids. Cochrane Database of Systematic Reviews”. 《The Cochrane Database of Systematic Reviews》 (John Wiley & Sons, Ltd) (11): CD010254. doi:10.1002/14651858.cd010254.pub2. PMC 6463960. PMID 25415541.
Li, Yunxia; Jiang, Xuehua; Lan, Ke; Zhang, Ruoqi; Li, Xue; Jiang, Qian (2007년 10월 1일). “Pharmacokinetic Properties of Rosuvastatin After Single-Dose, Oral Administration in Chinese Volunteers: A Randomized, Open-Label, Three-Way Crossover Study”. 《Clinical Therapeutics》 29 (10): 2194–2203. doi:10.1016/j.clinthera.2007.10.005. ISSN 0149-2918. PMID 18042475.
Bergman, Ebba; Lundahl, Anna; Fridblom, Patrik; Hedeland, Mikael; Bondesson, Ulf; Knutson, Lars; Lennernäs, Hans (2009년 12월 1일). “Enterohepatic Disposition of Rosuvastatin in Pigs and the Impact of Concomitant Dosing with Cyclosporine and Gemfibrozil”. 《Drug Metabolism and Disposition》 37 (12): 2349–2358. doi:10.1124/dmd.109.029363. ISSN 1521-009X. PMID 19773540. S2CID 24783238.

dailymed.nlm.nih.gov

“Crestor- rosuvastatin calcium tablet, film coated”. 《DailyMed》. 2018년 11월 9일. 2020년 3월 14일에 확인함.
“Viberzi- eluxadoline tablet, film coated”. 《DailyMed》. 2018년 6월 19일. 2020년 3월 14일에 확인함.

nlm.nih.gov

“Rosuvastatin”. 《MedlinePlus》. U.S. National Library of Medicine. 2012년 6월 15일. 2012년 12월 1일에 확인함.

toxnet.nlm.nih.gov

“Rosuvastatin”. 《LactMed》. U.S. National Library of Medicine. 2016년 1월 7일에 원본 문서에서 보존된 문서. 2012년 12월 1일에 확인함.

pqarchiver.com (Global: 490^th place; Korean: 1,676^th place)

pqasb.pqarchiver.com

Starkey, Jonathan (2010년 7월 1일). “AstraZeneca patent upheld”. 《The News Journal》 (Wilmington, Delaware). 2013년 1월 31일에 원본 문서에서 보존된 문서. 2012년 4월 25일에 확인함. (구독 필요)

prnewswire.com (Global: 406^th place; Korean: 621^st place)

“Crestor Patent Upheld By US Court” (보도 자료). AstraZeneca. 2010년 6월 29일. 2012년 4월 25일에 확인함 – PR Newswire 경유.
“Mylan Launches Generic Crestor Tablets” (보도 자료). Mylan. 2016년 7월 20일 – PR Newswire 경유.

reuters.com (Global: 49^th place; Korean: 110^th place)

Berkrot, Bill; Hals, Tom (2010년 6월 29일). “U.S. judge rules AstraZeneca Crestor patent valid”. Reuters. 2013년 6월 25일에 원본 문서에서 보존된 문서. 2012년 4월 25일에 확인함.

semanticscholar.org (Global: 11^th place; Korean: 310^th place)

api.semanticscholar.org

Aggarwal, RK; Showkathali, R (June 2013). “Rosuvastatin calcium in acute coronary syndromes”. 《Expert Opinion on Pharmacotherapy》 14 (9): 1215–1227. doi:10.1517/14656566.2013.789860. PMID 23574635. S2CID 20221457.
Sattar, N; Preiss, D; Murray, HM; Welsh, P; Buckley, BM; de Craen, AJ; Seshasai, SR; McMurray, JJ; Freeman, DJ; Jukema, JW; Macfarlane, PW; Packard, CJ; Stott, DJ; Westendorp, RG; Shepherd, J; Davis, BR; Pressel, SL; Marchioli, R; Marfisi, RM; Maggioni, AP; Tavazzi, L; Tognoni, G; Kjekshus, J; Pedersen, TR; Cook, TJ; Gotto, AM; Clearfield, MB; Downs, JR; Nakamura, H; Ohashi, Y; Mizuno, K; Ray, KK; Ford, I (2010년 2월 27일). “Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.”. 《Lancet》 375 (9716): 735–42. doi:10.1016/S0140-6736(09)61965-6. PMID 20167359. S2CID 11544414.
Bergman, Ebba; Lundahl, Anna; Fridblom, Patrik; Hedeland, Mikael; Bondesson, Ulf; Knutson, Lars; Lennernäs, Hans (2009년 12월 1일). “Enterohepatic Disposition of Rosuvastatin in Pigs and the Impact of Concomitant Dosing with Cyclosporine and Gemfibrozil”. 《Drug Metabolism and Disposition》 37 (12): 2349–2358. doi:10.1124/dmd.109.029363. ISSN 1521-009X. PMID 19773540. S2CID 24783238.

semanticscholar.org

Aggarwal, RK; Showkathali, R (June 2013). “Rosuvastatin calcium in acute coronary syndromes”. 《Expert Opinion on Pharmacotherapy》 14 (9): 1215–1227. doi:10.1517/14656566.2013.789860. PMID 23574635. S2CID 20221457.
Bergman, Ebba; Lundahl, Anna; Fridblom, Patrik; Hedeland, Mikael; Bondesson, Ulf; Knutson, Lars; Lennernäs, Hans (2009년 12월 1일). “Enterohepatic Disposition of Rosuvastatin in Pigs and the Impact of Concomitant Dosing with Cyclosporine and Gemfibrozil”. 《Drug Metabolism and Disposition》 37 (12): 2349–2358. doi:10.1124/dmd.109.029363. ISSN 1521-009X. PMID 19773540. S2CID 24783238.

web.archive.org (Global: 1^st place; Korean: 1^st place)

“Rosuvastatin”. 《LactMed》. U.S. National Library of Medicine. 2016년 1월 7일에 원본 문서에서 보존된 문서. 2012년 12월 1일에 확인함.
“FDA Alert (03/2005) - Rosuvastatin Calcium (marketed as Crestor) Information”. U.S. Food and Drug Administration (FDA). 2005년 3월 14일. 2005년 3월 5일에 원본 문서에서 보존된 문서. 2005년 3월 20일에 확인함. - This page is subject to change; the date reflects the last revision date.
Nissen SE, Nicholls SJ, Sipahi I 외 (2006). “Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial” (PDF). 《JAMA》 295 (13): 1556–65. doi:10.1001/jama.295.13.jpc60002. PMID 16533939. 2007년 9월 29일에 원본 문서 (PDF)에서 보존된 문서.
“Core Data Sheet, Crestor Tablets” (PDF). AstraZeneca. June 17, 2003. May 8, 2005에 원본 문서 (PDF)에서 보존된 문서. March 20, 2005에 확인함. - NOTE: this is provider-oriented information and should not be used without the supervision of a physician.
“FDA Approves New Drug for Lowering Cholesterol”. Food and Drug Administration. 2003년 8월 12일. 2005년 2월 7일에 원본 문서에서 보존된 문서. 2005년 3월 20일에 확인함.
Berkrot, Bill; Hals, Tom (2010년 6월 29일). “U.S. judge rules AstraZeneca Crestor patent valid”. Reuters. 2013년 6월 25일에 원본 문서에서 보존된 문서. 2012년 4월 25일에 확인함.
“COST COMPARISON CHARTS” (PDF). REGIONAL DRUG AND THERAPEUTICS CENTRE (NEWCASTLE). August 2018. 2018년 10월 20일에 원본 문서 (PDF)에서 보존된 문서. 2021년 5월 16일에 확인함.

webmd.com (Global: 1,169^th place; Korean: 735^th place)

“FDA Updates Crestor Warning Information”. 《WebMD》. 2005년 3월 3일. 2020년 3월 14일에 확인함.

who.int (Global: 195^th place; Korean: 98^th place)

“International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names (Rec. INN): List 45” (PDF). World Health Organization. 2001. 50쪽. 2016년 11월 29일에 확인함.

worldcat.org (Global: 5^th place; Korean: 11^th place)

Li, Yunxia; Jiang, Xuehua; Lan, Ke; Zhang, Ruoqi; Li, Xue; Jiang, Qian (2007년 10월 1일). “Pharmacokinetic Properties of Rosuvastatin After Single-Dose, Oral Administration in Chinese Volunteers: A Randomized, Open-Label, Three-Way Crossover Study”. 《Clinical Therapeutics》 29 (10): 2194–2203. doi:10.1016/j.clinthera.2007.10.005. ISSN 0149-2918. PMID 18042475.
Bergman, Ebba; Lundahl, Anna; Fridblom, Patrik; Hedeland, Mikael; Bondesson, Ulf; Knutson, Lars; Lennernäs, Hans (2009년 12월 1일). “Enterohepatic Disposition of Rosuvastatin in Pigs and the Impact of Concomitant Dosing with Cyclosporine and Gemfibrozil”. 《Drug Metabolism and Disposition》 37 (12): 2349–2358. doi:10.1124/dmd.109.029363. ISSN 1521-009X. PMID 19773540. S2CID 24783238.

로수바스타틴 (Korean Wikipedia)

aafp.org (Global: 1,916th place; Korean: 987th place)

ama-assn.org (Global: 3,257th place; Korean: 2,201st place)

jama.ama-assn.org

archive.today (Global: 14th place; Korean: 15th place)

books.google.com (Global: 3rd place; Korean: 9th place)

cigna.com (Global: low place; Korean: low place)

clincalc.com (Global: 3,912th place; Korean: 2,490th place)

clinicaltherapeutics.com (Global: low place; Korean: low place)

crestor.info (Global: low place; Korean: low place)

delawareonline.com (Global: 4,565th place; Korean: low place)

doi.org (Global: 2nd place; Korean: 3rd place)

dx.doi.org

drugs.com (Global: 399th place; Korean: 141st place)

fda.gov (Global: 447th place; Korean: 433rd place)

fda.gov

accessdata.fda.gov

gmmmg.nhs.uk (Global: low place; Korean: low place)

latimes.com (Global: 22nd place; Korean: 169th place)

lww.com (Global: 2,769th place; Korean: 1,748th place)

journals.lww.com

nih.gov (Global: 4th place; Korean: 4th place)

ncbi.nlm.nih.gov

dailymed.nlm.nih.gov

nlm.nih.gov

toxnet.nlm.nih.gov

pqarchiver.com (Global: 490th place; Korean: 1,676th place)

pqasb.pqarchiver.com

prnewswire.com (Global: 406th place; Korean: 621st place)

reuters.com (Global: 49th place; Korean: 110th place)

semanticscholar.org (Global: 11th place; Korean: 310th place)

api.semanticscholar.org

semanticscholar.org

web.archive.org (Global: 1st place; Korean: 1st place)

webmd.com (Global: 1,169th place; Korean: 735th place)

who.int (Global: 195th place; Korean: 98th place)

worldcat.org (Global: 5th place; Korean: 11th place)

aafp.org (Global: 1,916^th place; Korean: 987^th place)

ama-assn.org (Global: 3,257^th place; Korean: 2,201^st place)

archive.today (Global: 14^th place; Korean: 15^th place)

books.google.com (Global: 3^rd place; Korean: 9^th place)

clincalc.com (Global: 3,912^th place; Korean: 2,490^th place)

delawareonline.com (Global: 4,565^th place; Korean: low place)

doi.org (Global: 2^nd place; Korean: 3^rd place)

drugs.com (Global: 399^th place; Korean: 141^st place)

fda.gov (Global: 447^th place; Korean: 433^rd place)

latimes.com (Global: 22^nd place; Korean: 169^th place)

lww.com (Global: 2,769^th place; Korean: 1,748^th place)

nih.gov (Global: 4^th place; Korean: 4^th place)

pqarchiver.com (Global: 490^th place; Korean: 1,676^th place)

prnewswire.com (Global: 406^th place; Korean: 621^st place)

reuters.com (Global: 49^th place; Korean: 110^th place)

semanticscholar.org (Global: 11^th place; Korean: 310^th place)

web.archive.org (Global: 1^st place; Korean: 1^st place)

webmd.com (Global: 1,169^th place; Korean: 735^th place)

who.int (Global: 195^th place; Korean: 98^th place)

worldcat.org (Global: 5^th place; Korean: 11^th place)